Brief: Hyphens Pharma International Says Unit Entered Exclusive License, Supply Deal

Hyphens Pharma International

12/03/2024 10:27

March 12 (Reuters) - Hyphens Pharma International Ltd
 HYPH.SI :
    * UNIT ENTERED EXCLUSIVE LICENSE, SUPPLY AND
COMMERCIALISATION
DEAL WITH MC2 THERAPEUTICS
    * WYNZORA CREAM APPROVED FOR UNITED STATES AND COUNTRIES IN
EUROPE
    * UNDER DEAL, GROUP WILL PAY MC2 TOTAL EUR 2.5 MILLION
    * DEAL FOR EXCLUSIVE RIGHTS TO REGISTER AND COMMERCIALISE 
WYNZORA
CREAM


Further company coverage:  HYPH.SI